FunPep Company Limited
4881 | T
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- Japan
- Address:
- 茨木市彩都あさぎ七丁目７−１５
- Website:
- https://www.funpep.co.jp/en/
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
FunPep Company Limited is a pioneering Japanese biotechnology firm specializing in the development of peptide-based pharmaceuticals. Based in Tokyo, the company focuses on harnessing the therapeutic potential of peptides, which are vital in regulating various bodily functions. FunPep's innovative pipeline includes allergy vaccines and functional peptides, with ongoing clinical trials aimed at inducing immune responses and advancing next-generation formulation technologies. The company actively engages in strategic collaborations, such as its recent partnership with BIOASTER, to enhance its research and development capabilities. With a commitment to improving healthcare through cutting-edge science, FunPep stands at the forefront of the pharmaceutical landscape in Japan and beyond.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-04-01 08:30 |
Inside Information Statement
臨時報告書
|
Japanese | 23.2 KB | |
| 2025-03-28 08:16 |
Regulatory News Service
確認書
|
Japanese | 8.5 KB | |
| 2025-03-28 08:15 |
Annual Report
有価証券報告書－第12期(2024/01/01－2024/12/31)
|
Japanese | 1.6 MB | |
| 2025-03-28 08:15 |
Internal Control over Financial Reporting
内部統制報告書－第12期(2024/01/01－2024/12/31)
|
Japanese | 23.6 KB | |
| 2025-02-21 07:30 |
Prospectus
有価証券届出書（組込方式）
|
Japanese | 447.3 KB | |
| 2024-08-08 09:01 |
Regulatory News Service
確認書
|
Japanese | 8.4 KB | |
| 2024-08-08 09:00 |
Interim Report
半期報告書－第12期(2024/01/01－2024/12/31)
|
Japanese | 283.1 KB | |
| 2024-08-08 03:00 |
Inside Information Statement
臨時報告書
|
Japanese | 21.3 KB | |
| 2024-07-05 08:05 |
Prospectus
有価証券届出書（組込方式）
|
Japanese | 391.3 KB | |
| 2024-05-13 08:00 |
Regulatory News Service
確認書
|
Japanese | 8.4 KB | |
| 2024-05-13 08:00 |
Quarterly Report
四半期報告書－第12期第1四半期(2024/01/01－2024/03/31)
|
Japanese | 238.2 KB | |
| 2024-04-01 08:05 |
Inside Information Statement
臨時報告書
|
Japanese | 27.7 KB | |
| 2024-03-28 07:15 |
Regulatory News Service
確認書
|
Japanese | 8.5 KB | |
| 2024-03-28 07:15 |
Annual Report
有価証券報告書－第11期(2023/01/01－2023/12/31)
|
Japanese | 1.6 MB | |
| 2024-03-28 07:15 |
Internal Control over Financial Reporting
内部統制報告書－第11期(2023/01/01－2023/12/31)
|
Japanese | 23.5 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Nippon Shinyaku Co.,Ltd. | Japan | 4516 | |
|
Noile-Immune Biotech Inc. | Japan | 4893 | |
|
Novartis AG | Switzerland | NOVN | |
|
Nur Ink Innovations Ltd. | Israel | NURI | |
|
Nxera Pharma Co., Ltd. | Japan | 4565 | |
|
ObsEva SA | Switzerland | OBSN | |
|
ODI Pharma AB | Sweden | ODI | |
|
Oncolys BioPharma Inc. | Japan | 4588 | |
|
OncoTherapy Science, Inc. | Japan | 4564 | |
|
OncoZenge AB | Sweden | ONCOZ |